Identification of biomarker patterns in a biological sample, such as serum or plasma, can dramatically increase the success of almost any drug development program. RBM's MAP approach provides investigators with a reliable platform that allows discovery, validation, and clinical use of these patterns in a cost-effective, efficient manner.
RBM's Human MAPs represent the most comprehensive menu of quantitative, multiplexed immunoassays commercially available. Our Human MAPs provide insight into multiple pathways to help better understand the underlying biology.
Please click on the following MAPs for a complete list of included analytes.
|Serum or plasma||Other fluids*|
|Human DiscoveryMAP®||500 µL||3 mL|
|Human ExplorerMAP™||220 µL||800 µL|
|HumanMAP®||120 µL||650 µL|
|Human CardiovascularMAP®||150 µL||700 µL|
|Human AngiogenesisMAP®||140 µL||500 µL|
|Human InflammationMAP®||60 µL||300 µL|
|Human ImmunoMAP®||140 µL||650 µL|
|Human MetabolicMAP®||90 µL||300 µL|
|Human KidneyMAP®||60 µL||110 µL|
|Human CytokineMAP® A||60 µL||125 µL|
|Human CytokineMAP® B||50 µL||125 µL|
* Cerebrospinal fluid, urine, tissue culture supernatants, bronchoalveolar lavage, synovial fluid, tissue extracts, tears, skin washings, etc.
If your volumes are not sufficient, please contact RBM for other options and information.
RBM is a CLIA certified laboratory that supports GLP studies. All testing is performed to the highest standards of scientific quality in accordance with our standard operating procedures and applicable regulatory requirements.
Please click here to read more about our laboratory’s quality standards and MAP validation process.